Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 Jun;37:1409–1420.

Glucose Control and Diabetic Complications

Is tight control of IDDM justified?

Stan Lubin
PMCID: PMC2145395  PMID: 21229036

Abstract

Tight glucose control is clearly beneficial in the pregnant insulin-dependent diabetic. In other areas (retinopathy, established nephropathy, and hypoglycemia) the question whether tight control of diabetes is justified remains unanswered. Preliminary evidence suggests that tight control, if begun early, can prevent clinical nephropathy and neuropathy.

Full text

PDF
1409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adashi E. Y., Pinto H., Tyson J. E. Impact of maternal euglycemia on fetal outcome in diabetic pregnancy. Am J Obstet Gynecol. 1979 Feb 1;133(3):268–274. doi: 10.1016/0002-9378(79)90677-x. [DOI] [PubMed] [Google Scholar]
  2. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
  3. Bale R. N. Brain damage in diabetes mellitus. Br J Psychiatry. 1973 Mar;122(568):337–341. doi: 10.1192/bjp.122.3.337. [DOI] [PubMed] [Google Scholar]
  4. Boulton A. J., Drury J., Clarke B., Ward J. D. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care. 1982 Jul-Aug;5(4):386–390. doi: 10.2337/diacare.5.4.386. [DOI] [PubMed] [Google Scholar]
  5. Brown D. M., Andres G. A., Hostetter T. H., Mauer S. M., Price R., Venkatachalam M. A. Kidney complications. Diabetes. 1982;31(Suppl 1 Pt 2):71–81. doi: 10.2337/diab.31.1.s71. [DOI] [PubMed] [Google Scholar]
  6. COLLYER R. T., HAZLETT B. E. Retinopathy and neuropathy in one hundred growth-onset diabetic patients. Can Med Assoc J. 1961 Dec 16;85:1328–1334. [PMC free article] [PubMed] [Google Scholar]
  7. Cahill G. F., Jr, Etzwiler L. D., Freinkel N. Editorial: "Control" and diabetes. N Engl J Med. 1976 Apr 29;294(18):1004–1005. doi: 10.1056/NEJM197604292941811. [DOI] [PubMed] [Google Scholar]
  8. Chase H. P., Jackson W. E., Hoops S. L., Cockerham R. S., Archer P. G., O'Brien D. Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA. 1989 Feb 24;261(8):1155–1160. [PubMed] [Google Scholar]
  9. Coustan D. R., Berkowitz R. L., Hobbins J. C. Tight metabolic control of overt diabetes in pregnancy. Am J Med. 1980 Jun;68(6):845–852. doi: 10.1016/0002-9343(80)90204-1. [DOI] [PubMed] [Google Scholar]
  10. Dahl-Jørgensen K., Brinchmann-Hansen O., Hanssen K. F., Ganes T., Kierulf P., Smeland E., Sandvik L., Aagenaes O. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1195–1199. doi: 10.1136/bmj.293.6556.1195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dahl-Jørgensen K., Brinchmann-Hansen O., Hanssen K. F., Sandvik L., Aagenaes O. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study. Br Med J (Clin Res Ed) 1985 Mar 16;290(6471):811–815. doi: 10.1136/bmj.290.6471.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Deckert T., Poulsen J. E., Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications. Diabetologia. 1978 Jun;14(6):363–370. doi: 10.1007/BF01228130. [DOI] [PubMed] [Google Scholar]
  13. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care. 1987 Jan-Feb;10(1):1–19. doi: 10.2337/diacare.10.1.1. [DOI] [PubMed] [Google Scholar]
  14. Doft B. H., Kingsley L. A., Orchard T. J., Kuller L., Drash A., Becker D. The association between long-term diabetic control and early retinopathy. Ophthalmology. 1984 Jul;91(7):763–769. doi: 10.1016/s0161-6420(84)34235-x. [DOI] [PubMed] [Google Scholar]
  15. Dorman J. S., Laporte R. E., Kuller L. H., Cruickshanks K. J., Orchard T. J., Wagener D. K., Becker D. J., Cavender D. E., Drash A. L. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes. 1984 Mar;33(3):271–276. doi: 10.2337/diab.33.3.271. [DOI] [PubMed] [Google Scholar]
  16. Eeg-Olofsson O. Hypoglycemia and neurological disturbances in children with diabetes mellitus. Acta Paediatr Scand Suppl. 1977;(270):91–96. doi: 10.1111/j.1651-2227.1977.tb15127.x. [DOI] [PubMed] [Google Scholar]
  17. Ehle A. L., Raskin P. Increased nerve conduction in diabetics after a year of improved glucoregulation. J Neurol Sci. 1986 Jul;74(2-3):191–197. doi: 10.1016/0022-510x(86)90104-8. [DOI] [PubMed] [Google Scholar]
  18. Engerman R., Bloodworth J. M., Jr, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes. 1977 Aug;26(8):760–769. doi: 10.2337/diab.26.8.760. [DOI] [PubMed] [Google Scholar]
  19. Eschwege E., Guyot-Argenton C., Aubry J. P., Tchobroutsky G. Effect of multiple daily insulin injections on the course of diabetic retinopathy. Diabetes. 1976 May;25(5):463–469. [PubMed] [Google Scholar]
  20. Feldt-Rasmussen B., Mathiesen E. R., Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986 Dec 6;2(8519):1300–1304. doi: 10.1016/s0140-6736(86)91433-9. [DOI] [PubMed] [Google Scholar]
  21. Feldt-Rasmussen B., Mathiesen E. R., Hegedüs L., Deckert T. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med. 1986 Mar 13;314(11):665–670. doi: 10.1056/NEJM198603133141101. [DOI] [PubMed] [Google Scholar]
  22. Felig P., Bergman M. Intensive ambulatory treatment of insulin-dependent diabetes. Ann Intern Med. 1982 Aug;97(2):225–230. doi: 10.7326/0003-4819-97-2-225. [DOI] [PubMed] [Google Scholar]
  23. Felsing W., Bibergeil H., Menzel R., Albrecht G., Felsing U., Dabels J., Reichel G., Lüder C. Results of treatment with continuous subcutaneous insulin infusion (CSII) in insulin-dependent (type I) diabetics. Exp Clin Endocrinol. 1984 Apr;83(2):136–142. doi: 10.1055/s-0029-1210322. [DOI] [PubMed] [Google Scholar]
  24. Fuhrmann K., Reiher H., Semmler K., Fischer F., Fischer M., Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care. 1983 May-Jun;6(3):219–223. doi: 10.2337/diacare.6.3.219. [DOI] [PubMed] [Google Scholar]
  25. Fuller J. H., McCartney P., Jarrett R. J., Keen H., Rose G., Shipley M. J., Hamilton P. J. Hyperglycaemia and coronary heart disease: the Whitehall study. J Chronic Dis. 1979;32(11-12):721–728. doi: 10.1016/0021-9681(79)90051-1. [DOI] [PubMed] [Google Scholar]
  26. Gabbe S. G., Mestman J. H., Freeman R. K., Goebelsmann U. T., Lowensohn R. I., Nochimson D., Cetrulo C., Quilligan E. J. Management and outcome of pregnancy in diabetes mellitus, classes B to R. Am J Obstet Gynecol. 1977 Dec 1;129(7):723–732. doi: 10.1016/0002-9378(77)90388-x. [DOI] [PubMed] [Google Scholar]
  27. Gale E. A., Tattersall R. B. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet. 1979 May 19;1(8125):1049–1052. doi: 10.1016/s0140-6736(79)92950-7. [DOI] [PubMed] [Google Scholar]
  28. Gambardella S., Napoli A., Spallone V., Verrastro A. M., Lazzari R., Geraldini C., Sideri G., Menzinger G. Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics. J Endocrinol Invest. 1983 Oct;6(5):363–367. doi: 10.1007/BF03347617. [DOI] [PubMed] [Google Scholar]
  29. Goldgewicht C., Slama G., Papoz L., Tchobroutsky G. Hypoglycaemic reactions in 172 Type 1 (insulin-dependent) diabetic patients. Diabetologia. 1983 Feb;24(2):95–99. doi: 10.1007/BF00297389. [DOI] [PubMed] [Google Scholar]
  30. Goodkin G. Mortality factors in diabetes. A 20 year mortality study. J Occup Med. 1975 Nov;17(11):716–721. [PubMed] [Google Scholar]
  31. Graf R. J., Halter J. B., Pfeifer M. A., Halar E., Brozovich F., Porte D., Jr Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects. Ann Intern Med. 1981 Mar;94(3):307–311. doi: 10.7326/0003-4819-94-3-307. [DOI] [PubMed] [Google Scholar]
  32. Gregersen G. Diabetic neuropathy: influence of age, sex, metabolic control, and duration of diabetes on motor conduction velocity. Neurology. 1967 Oct;17(10):972–980. doi: 10.1212/wnl.17.10.972. [DOI] [PubMed] [Google Scholar]
  33. HARDIN R. C., JACKSON R. L., JOHNSTON T. L., KELLY H. G. The development of diabetic retinopathy; effects of duration and control of diabetes. Diabetes. 1956 Sep-Oct;5(5):397–405. doi: 10.2337/diab.5.5.397. [DOI] [PubMed] [Google Scholar]
  34. Haumont D., Dorchy H., Pelc S. EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 1979 Dec;18(12):750–753. doi: 10.1177/000992287901801205. [DOI] [PubMed] [Google Scholar]
  35. Holman R. R., Dornan T. L., Mayon-White V., Howard-Williams J., Orde-Peckar C., Jenkins L., Steemson J., Rolfe R., Smith B., Barbour D. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study. Lancet. 1983 Jan 29;1(8318):204–208. doi: 10.1016/s0140-6736(83)92586-2. [DOI] [PubMed] [Google Scholar]
  36. Ingelfinger F. J. Debatees on diabetes. N Engl J Med. 1977 May 26;296(21):1228–1230. doi: 10.1056/NEJM197705262962111. [DOI] [PubMed] [Google Scholar]
  37. JOHNSSON S. Retinopathy and nephropathy in diabetes mellitus: comparison of the effects of two forms of treatment. Diabetes. 1960 Jan-Feb;9:1–8. doi: 10.2337/diab.9.1.1. [DOI] [PubMed] [Google Scholar]
  38. Jarrett R. J., Keen H. Hyperglycaemia and diabetes mellitus. Lancet. 1976 Nov 6;2(7993):1009–1012. doi: 10.1016/s0140-6736(76)90844-8. [DOI] [PubMed] [Google Scholar]
  39. Katsilambros N. Diabetic retinopathy and blood-sugar. Lancet. 1976 Dec 4;2(7997):1253–1253. doi: 10.1016/s0140-6736(76)91189-2. [DOI] [PubMed] [Google Scholar]
  40. Kennedy W. R., Navarro X., Goetz F. C., Sutherland D. E., Najarian J. S. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med. 1990 Apr 12;322(15):1031–1037. doi: 10.1056/NEJM199004123221503. [DOI] [PubMed] [Google Scholar]
  41. Kitzmiller J. L., Cloherty J. P., Younger M. D., Tabatabaii A., Rothchild S. B., Sosenko I., Epstein M. F., Singh S., Neff R. K. Diabetic pregnancy and perinatal morbidity. Am J Obstet Gynecol. 1978 Jul 1;131(5):560–580. doi: 10.1016/0002-9378(78)90120-5. [DOI] [PubMed] [Google Scholar]
  42. Klein R., Klein B. E., Moss S. E., Davis M. D., DeMets D. L. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984 Apr;102(4):520–526. doi: 10.1001/archopht.1984.01040030398010. [DOI] [PubMed] [Google Scholar]
  43. Krolewski A. S., Warram J. H., Christlieb A. R., Busick E. J., Kahn C. R. The changing natural history of nephropathy in type I diabetes. Am J Med. 1985 May;78(5):785–794. doi: 10.1016/0002-9343(85)90284-0. [DOI] [PubMed] [Google Scholar]
  44. Krolewski A. S., Warram J. H., Rand L. I., Christlieb A. R., Busick E. J., Kahn C. R. Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study. Diabetes Care. 1986 Sep-Oct;9(5):443–452. doi: 10.2337/diacare.9.5.443. [DOI] [PubMed] [Google Scholar]
  45. Krolewski A. S., Warram J. H., Rand L. I., Kahn C. R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med. 1987 Nov 26;317(22):1390–1398. doi: 10.1056/NEJM198711263172206. [DOI] [PubMed] [Google Scholar]
  46. Lauritzen T., Frost-Larsen K., Larsen H. W., Deckert T. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet. 1983 Jan 29;1(8318):200–204. doi: 10.1016/s0140-6736(83)92585-0. [DOI] [PubMed] [Google Scholar]
  47. Leveno K. J., Hauth J. C., Gilstrap L. C., 3rd, Whalley P. J. Appraisal of "rigid" blood glucose control during pregnancy in the overtly diabetic woman. Am J Obstet Gynecol. 1979 Dec 1;135(7):853–862. doi: 10.1016/0002-9378(79)90812-3. [DOI] [PubMed] [Google Scholar]
  48. MARKS H. H. LONGEVITY AND MORTALITY OF DIABETICS. Am J Public Health Nations Health. 1965 Mar;55:416–423. doi: 10.2105/ajph.55.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Mathiesen E. R., Oxenbøll B., Johansen K., Svendsen P. A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jun;26(6):406–410. doi: 10.1007/BF00262210. [DOI] [PubMed] [Google Scholar]
  50. Mauer S. M., Brown D. M., Matas A. J., Steffes M. W. Effects of pancreatic islet transplantation on the increased urinary albumin excretion rates in intact and uninephrectomized rats with diabetes mellitus. Diabetes. 1978 Sep;27(9):959–964. doi: 10.2337/diab.27.9.959. [DOI] [PubMed] [Google Scholar]
  51. Mauer S. M., Steffes M. W., Sutherland D. E., Najarian-S, Michael A. F., Brown D. M. Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes. 1975 Mar;24(3):280–285. doi: 10.2337/diab.24.3.280. [DOI] [PubMed] [Google Scholar]
  52. Miller E., Hare J. W., Cloherty J. P., Dunn P. J., Gleason R. E., Soeldner J. S., Kitzmiller J. L. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med. 1981 May 28;304(22):1331–1334. doi: 10.1056/NEJM198105283042204. [DOI] [PubMed] [Google Scholar]
  53. Mogensen C. E., Christensen C. K. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984 Jul 12;311(2):89–93. doi: 10.1056/NEJM198407123110204. [DOI] [PubMed] [Google Scholar]
  54. Mogensen C. E., Steffes M. W., Deckert T., Christiansen J. S. Functional and morphological renal manifestations in diabetes mellitus. Diabetologia. 1981 Aug;21(2):89–93. doi: 10.1007/BF00251272. [DOI] [PubMed] [Google Scholar]
  55. Nyberg G., Blohmé G., Nordén G. Impact of metabolic control in progression of clinical diabetic nephropathy. Diabetologia. 1987 Feb;30(2):82–86. doi: 10.1007/BF00274576. [DOI] [PubMed] [Google Scholar]
  56. Parving H. H., Oxenbøll B., Svendsen P. A., Christiansen J. S., Andersen A. R. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 1982 Aug;100(4):550–555. doi: 10.1530/acta.0.1000550. [DOI] [PubMed] [Google Scholar]
  57. Paz-Guevara A. T., Hsu T. H., White P. Juvenile diabetes mellitus after forty years. Diabetes. 1975 Jun;24(6):559–565. doi: 10.2337/diab.24.6.559. [DOI] [PubMed] [Google Scholar]
  58. Pietri A., Ehle A. L., Raskin P. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps. Diabetes. 1980 Aug;29(8):668–671. doi: 10.2337/diab.29.8.668. [DOI] [PubMed] [Google Scholar]
  59. Potter J., Clarke P., Gale E. A., Dave S. H., Tattersall R. B. Insulin-induced hypoglycaemia in an accident and emergency department: the tip of an iceberg? Br Med J (Clin Res Ed) 1982 Oct 23;285(6349):1180–1182. doi: 10.1136/bmj.285.6349.1180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Puklin J. E., Tamborlane W. V., Felig P., Genel M., Sherwin R. S. Influence of long-term insulin infusion pump treatment of type I diabetes on diabetic retinopathy. Ophthalmology. 1982 Jul;89(7):735–747. doi: 10.1016/s0161-6420(82)34730-2. [DOI] [PubMed] [Google Scholar]
  61. Raskin P., Rosenstock J. Blood glucose control and diabetic complications. Ann Intern Med. 1986 Aug;105(2):254–263. doi: 10.7326/0003-4819-105-2-254. [DOI] [PubMed] [Google Scholar]
  62. Reeves M. L., Seigler D. E., Ryan E. A., Skyler J. S. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med. 1982 Apr;72(4):673–680. doi: 10.1016/0002-9343(82)90479-x. [DOI] [PubMed] [Google Scholar]
  63. Rosenstock J., Friberg T., Raskin P. Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus. Am J Med. 1986 Dec;81(6):1012–1018. doi: 10.1016/0002-9343(86)90398-0. [DOI] [PubMed] [Google Scholar]
  64. Roversi G. D., Gargiulo M., Nicolini U., Pedretti E., Marini A., Barbarani V., Peneff P. A new approach to the treatment of diabetic pregnant women. Report of 479 cases seen from 1963 to 1975. Am J Obstet Gynecol. 1979 Nov 1;135(5):567–576. doi: 10.1016/s0002-9378(16)32978-7. [DOI] [PubMed] [Google Scholar]
  65. Service F. J., Rizza R. A., Daube J. R., O'Brien P. C., Dyck P. J. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia. 1985 Oct;28(10):722–727. doi: 10.1007/BF00265018. [DOI] [PubMed] [Google Scholar]
  66. Siperstein M. D., Foster D. W., Knowles H. C., Levine R., Madison L. L., Roth J. Control of blood glucose and diabetic vascular disease. N Engl J Med. 1977 May 5;296(18):1060–1063. doi: 10.1056/NEJM197705052961812. [DOI] [PubMed] [Google Scholar]
  67. Solders G., Wilczek H., Gunnarsson R., Tydén G., Persson A., Groth C. G. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet. 1987 Nov 28;2(8570):1232–1235. doi: 10.1016/s0140-6736(87)91851-4. [DOI] [PubMed] [Google Scholar]
  68. Szabo A. J., Stewart A. G., Joron G. E. Factors associated with increased prevalence of diabetic retinopathy: a clinical survey. Can Med Assoc J. 1967 Aug 5;97(6):286–292. [PMC free article] [PubMed] [Google Scholar]
  69. Tamborlane W. V., Puklin J. E., Bergman M., Verdonk C., Rudolf M. C., Felig P., Genel M., Sherwin R. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care. 1982 May-Jun;5 (Suppl 1):58–64. [PubMed] [Google Scholar]
  70. Tamborlane W. V., Sherwin R. S., Genel M., Felig P. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med. 1979 Mar 15;300(11):573–578. doi: 10.1056/NEJM197903153001101. [DOI] [PubMed] [Google Scholar]
  71. Teutsch S. M., Herman W. H., Dwyer D. M., Lane J. M. Mortality among diabetic patients using continuous subcutaneous insulin-infusion pumps. N Engl J Med. 1984 Feb 9;310(6):361–368. doi: 10.1056/NEJM198402093100606. [DOI] [PubMed] [Google Scholar]
  72. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes. 1986 May;35(5):530–545. [PubMed] [Google Scholar]
  73. Tunbridge W. M. Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association. Lancet. 1981 Sep 12;2(8246):569–572. doi: 10.1016/s0140-6736(81)90950-8. [DOI] [PubMed] [Google Scholar]
  74. Unger R. H. Meticulous control of diabetes: benefits, risks, and precautions. Diabetes. 1982 Jun;31(6 Pt 1):479–483. doi: 10.2337/diab.31.6.479. [DOI] [PubMed] [Google Scholar]
  75. Viberti G. C., Bilous R. W., Mackintosh D., Bending J. J., Keen H. Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) 1983 Feb 19;286(6365):598–602. doi: 10.1136/bmj.286.6365.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Viberti G. C., Hill R. D., Jarrett R. J., Argyropoulos A., Mahmud U., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982 Jun 26;1(8287):1430–1432. doi: 10.1016/s0140-6736(82)92450-3. [DOI] [PubMed] [Google Scholar]
  77. Vicari A. M., Margonato A., Petrelli P., Vicedomini G. G., Pozza G. Plasma beta-thromboglobulin concentration at rest and after physical exercise in complicated and uncomplicated diabetes mellitus. Diabete Metab. 1984 Oct;10(4):235–238. [PubMed] [Google Scholar]
  78. WHITE P. Pregnancy complicating diabetes. Am J Med. 1949 Nov;7(5):609–616. doi: 10.1016/0002-9343(49)90382-4. [DOI] [PubMed] [Google Scholar]
  79. Ward J. D., Barnes C. G., Fisher D. J., Jessop J. D., Baker R. W. Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet. 1971 Feb 27;1(7696):428–430. doi: 10.1016/s0140-6736(71)92415-9. [DOI] [PubMed] [Google Scholar]
  80. Weber B., Burger W., Hartmann R., Hövener G., Malchus R., Oberdisse U. Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1986 Jan;29(1):23–29. doi: 10.1007/BF02427276. [DOI] [PubMed] [Google Scholar]
  81. Wiseman M. J., Saunders A. J., Keen H., Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med. 1985 Mar 7;312(10):617–621. doi: 10.1056/NEJM198503073121004. [DOI] [PubMed] [Google Scholar]
  82. Wiseman M. J., Viberti G. C., Keen H. Threshold effect of plasma glucose in the glomerular hyperfiltration of diabetes. Nephron. 1984;38(4):257–260. doi: 10.1159/000183319. [DOI] [PubMed] [Google Scholar]
  83. Young R. J., Ewing D. J., Clarke B. F. Nerve function and metabolic control in teenage diabetics. Diabetes. 1983 Feb;32(2):142–147. doi: 10.2337/diab.32.2.142. [DOI] [PubMed] [Google Scholar]
  84. Ziegler D., Wiefels K., Dannehl K., Gries F. A. Effects of one year of near-normoglycemia on peripheral nerve function in type 1 (insulin-dependent) diabetic patients. Klin Wochenschr. 1988 May 2;66(9):388–396. doi: 10.1007/BF01737942. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES